French Questionnaire on Quality of Life in Polycystic Ovary Syndrome
Checks a French version of a quality-of-life questionnaire in women with polycystic ovary syndrome.
Plain-language title generated from the registry record
Registry title: Translation and Validation of the French mPCOSQ (mPCOSQ-F).
Key facts
- Where
- Reims, FranceSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for women aged 18 to 45 with polycystic ovary syndrome (PCOS) who speak French. They fill in quality-of-life questionnaires.
- Age
- 18 to 45 years
- Sex
- Women only
- Disease stage
- Diagnosis of polycystic ovary syndrome (PCOS) made by the international recommendations published in 2023.
Main reasons for not taking part
- Adrenal hyperplasia, an androgen-producing tumor, Cushing's syndrome or a thyroid disorder
- Pregnancy or breast-feeding
- Under legal protection
Read by machine on 12 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 45 years old?
Source: NCT07016035, who can take part
Where in France
- Damien JOLLYReims, FranceContact: Sara BARRAUDTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- CHU de Reims
- Trial code
- NCT07016035
- Record updated
- 7 August 2025
- Original description
This study is a prospective, observational, bicentric study, evaluating the validity and reliability of a French version of the mPCOSQ questionnaire (mPCOSQ-F), used to assess health-related quality of life (HRQOL) in women with polycystic ovary syndrome.Read full original descriptionShow less
Translation and Validation of the French Version of the Health-related Quality of Life Questionnaire for the Polycystic Ovary Syndrome: the mPCOSQ-F.
This study is a prospective, observational, bicentric study, evaluating the validity and reliability of a French version of the mPCOSQ questionnaire (mPCOSQ-F), used to assess health-related quality of life (HRQOL) in women with polycystic ovary syndrome.
The first stage of the study consisted in translating the questionnaire from English to French.
Patients agreeing to take part in the study will complete the mPCOSQ-F and the SF-36 (generic HRQOL questionnaire). After 1 to 2 weeks, patients will receive the mPCOSQ-F and complete it again.
Inclusion: Women aged 18 to 45; Fluent in french; Having a diagnosis of PCOS according to the international recommendations published in 2023; Willing to participate in the study; Affiliated to the french social security system.
Exclusion: Diagnosis of adrenal hyperplasia, androgen-producing tumor, Cushing's syndrome, or thyroid disorder; Pregnancy or breast-feeding; Under legal protection.